Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Beginning to Address an Implementation Gap in Asthma: Clinicians’ Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States

The Journal of Allergy and Clinical Immunology In Practice(2023)10.1016/j.jaip.2023.05.023Source: DataRank Database

Beginning to Address an Implementation Gap in Asthma: Clinicians’ Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2023). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.21)OA: hybridTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Tejas C. Sekhar ORCID,Vanessa Chen ORCID,Kathryn Blake ORCID,Kaharu Sumino ORCID,Aimee S. James ORCID

Live enrichment

PubMed:37245736 PMC:PMC12289451 OpenAlex:https://openalex.org/W4378472363

National Institutes of Health

Grant: KL2-TR002346

National Institutes of Health

Grant: UL1TR002345

NHLBI NIH HHS

Grant: L30 HL149019

NCATS NIH HHS

Grant: KL2 TR002346

American Lung Association

National Center for Advancing Translational Sciences

FWCI

3.21

Citation Percentile

0.9%

Influential Citations

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttp://www.jaci-inpractice.org/article/S2213219823005615/pdf

HYBRIDhttp://www.jaci-inpractice.org/article/S2213219823005615/pdf

publisherhttp://www.jaci-inpractice.org/article/S2213219823005615/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213219823005615?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213219823005615?httpAccept=text/plain

Fields of Study

Asthma and respiratory diseasesInhalation and Respiratory Drug DeliveryDelphi Technique in ResearchMedicineAdultHumansUnited StatesBudesonideAnti-Asthmatic AgentsEthanolaminesAdministration, InhalationAsthmaBudesonide, Formoterol Fumarate Drug CombinationFormoterol FumarateNebulizers and VaporizersAdrenal Cortex HormonesDrug Combinations

MeSH Terms

Formoterol FumarateBudesonide, Formoterol Fumarate Drug CombinationAdministration, InhalationAdrenal Cortex HormonesAdultAsthmaDrug CombinationsEthanolaminesHumansNebulizers and VaporizersUnited StatesAnti-Asthmatic AgentsBudesonide

Keywords

FormoterolMedicineInhalerAsthmaFormularyBudesonideIntensive care medicineFamily medicineInternal medicineQualitative StudyInhalersAsthma GuidelinesDissemination And Implementation Science

Beginning to Address an Implementation Gap in Asthma: Clinicians’ Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States

FAIR Checklist

Authors (10)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)